NSE filing, NSE: OMAXE. Summary written from the filing by ALFA Finder's alert engine.
Omaxe Ltd: key numbers
- Share price
- ₹98.36
- Market cap
- ₹1,799 Cr
- Revenue (annual)
- ₹1,253 Cr
- Net profit (annual)
- ₹-696.9 Cr
- P/E (TTM)
- -4.9×Sector 33.7×
- Promoter holding
- 74.14%+0.00% QoQ
- FII holding
- 4.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omaxe Ltd
All →Omaxe Q2 FY27 Results: Net Loss of ₹25.6 Cr, Loss Narrows
Omaxe Ltd reported revenue from operations of ₹575.5 Cr (+79.4% YoY) and a net loss of ₹25.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹25.6 Cr
Omaxe Merger & Restructuring Worth ₹0.01 Cr
Omaxe Limited approved incorporating a wholly owned subsidiary for real estate PPP projects. The subsidiary's subscription cost is Rs 1,00,000 for 100% equity.
- Value
- ₹0.01 Cr
Omaxe Board Meeting Date
Omaxe Ltd scheduled a board meeting on October 27, 2026, to approve the standalone and consolidated financial results for the quarter ended September 30, 2026.
Omaxe Other Announcement
Omaxe Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Omaxe Product Launch
Omaxe Ltd announced the launch of a new commercial and service apartment project at 'Eternity - 2', targeting both domestic and international markets.
Omaxe Regulatory Approval
Omaxe Ltd received RERA registration for its 'Eternity - 2' commercial and service apartment project in Mathura. The approval facilitates sales, marketing, and project development.
- From
- Uttar Pradesh Real Estate Regulatory Authority
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr